| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/01/2005 | US20050265975 Method for selective inactivation of viral replication |
| 12/01/2005 | US20050265973 Chimeric adenoviruses for use in cancer treatment |
| 12/01/2005 | US20050265972 A genetic construct containing a glucose inducible regulatory element with a pair of CACGTG nucleotide sequences and confer human proinsulin expression in host hepatocyte cells; therapy for diabetes |
| 12/01/2005 | US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant |
| 12/01/2005 | US20050265970 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis |
| 12/01/2005 | US20050265965 Modified cytokines for use in cancer therapy |
| 12/01/2005 | US20050265961 Biodegradable poly(beta-amino esters) and uses thereof |
| 12/01/2005 | US20050265957 Polymerized formamides for use in delivery of compounds to cells |
| 12/01/2005 | US20050265927 Intranasal delivery of nucleic acid molecules |
| 12/01/2005 | DE102004023187A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 12/01/2005 | CA2824701A1 Modulation of glucose-6-phosphate translocase expression |
| 12/01/2005 | CA2567455A1 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 12/01/2005 | CA2567314A1 Cartilage and bone repair composition |
| 12/01/2005 | CA2566363A1 High affinity ny-eso t cell receptor |
| 12/01/2005 | CA2563801A1 Modulation of glucose-6-phosphatase translocase expression |
| 12/01/2005 | CA2562904A1 Cancer treatment using viruses and camptothecins |
| 11/30/2005 | EP1600511A1 Method of treating ischemic disease |
| 11/30/2005 | EP1600510A2 DNA sequences having anti-repressor activity |
| 11/30/2005 | EP1600506A2 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 11/30/2005 | EP1600210A1 Charged microspheres |
| 11/30/2005 | EP1600180A2 Antiproliferative drug and delivery device |
| 11/30/2005 | EP1599732A1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp (mtr1 / ltrpc5 / trpm5) |
| 11/30/2005 | EP1599600A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 11/30/2005 | EP1599593A2 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 11/30/2005 | EP1599592A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
| 11/30/2005 | EP1599591A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 11/30/2005 | EP1599586A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 11/30/2005 | EP1599577A2 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 11/30/2005 | EP1599503A2 Endothelial cell specific antibodies and uses thereof |
| 11/30/2005 | EP1599501A2 Modulation of the poliovirus receptor function |
| 11/30/2005 | EP1599231A2 Treatment of pain through expression of opioid receptors |
| 11/30/2005 | EP1599230A1 Process for generating multilayered particles |
| 11/30/2005 | EP1599223A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 11/30/2005 | EP1196586B1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 11/30/2005 | EP1192268B1 Nucleic acid binding of multi-zinc finger transcription factors |
| 11/30/2005 | EP1192181B1 Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor |
| 11/30/2005 | EP1185306B1 Use of viral vectors and charged molecules for gene therapy |
| 11/30/2005 | EP1078063B1 Basb029 polynucleotides and polypeptides from neisseria meningitis |
| 11/30/2005 | EP0960121B1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 11/30/2005 | EP0951541B1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 11/30/2005 | EP0808364B1 Human pancreatic cell lines: developments and uses |
| 11/30/2005 | EP0786005B9 Compositions for treatment of coronary artery diseases using gene therapy. |
| 11/30/2005 | EP0677099B1 Enhancer sequence for modulating expression in epithelial cells |
| 11/30/2005 | CN1703427A Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 11/30/2005 | CN1703420A Promoters exhibiting endothelial cell specificity and methods of using same |
| 11/30/2005 | CN1703248A Drug for auditory dysfunction |
| 11/30/2005 | CN1703229A Compositions and methods for treatment of prostate and other cancers |
| 11/30/2005 | CN1701816A Anti-tumor agent using interleukin-23 gene |
| 11/30/2005 | CN1701788A Avian polynucleotide vaccine formula |
| 11/30/2005 | CN1229496C Method and compositions for inducing tumor-specific cytotoxicity |
| 11/29/2005 | US6969609 nucleic acid sequences encoding a combination of B7, ICAM-1 and LFA-3, wherein expression of the nucleic acid sequences occurs in the host cel |
| 11/29/2005 | US6969599 Nucleic acids encoding tumor necrosis factor receptor TR10 |
| 11/29/2005 | US6969598 Methods for producing high titre vectors and compositions used in such methods |
| 11/29/2005 | US6969596 Polynucleotide encoding a human receptor tyrosine kinase |
| 11/29/2005 | US6969528 novel phosphorus-containing dendrimers which are functionalized at the level of the inner layers and which comprise protonated tertiary amines as ends, have particularly advantageous properties as vectors for transferring nucleic acids |
| 11/24/2005 | WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | WO2005111220A2 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 11/24/2005 | WO2005111208A1 Method of proliferating plasma cell |
| 11/24/2005 | WO2005111072A2 Notch-based fusion proteins and uses thereof |
| 11/24/2005 | WO2005111069A2 Morphogenic proteins and stimulatory factors in gene therapy |
| 11/24/2005 | WO2005110494A2 Methods and compositions for the inhibition of thrombus formation |
| 11/24/2005 | WO2005110493A2 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress |
| 11/24/2005 | WO2005110492A2 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | WO2005110491A2 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | WO2005110479A2 Treatments for pancreatic cancer |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110436A2 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | WO2005110433A1 Nonhuman animal having expression of bach2 artificially inhibited, and use thereof |
| 11/24/2005 | WO2005110374A1 Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005087931A8 Modified oncolytic viruses |
| 11/24/2005 | WO2005079844A3 Use for interleukin-33 (il33) and the il-33 receptor complex |
| 11/24/2005 | WO2005079267A3 Methods for protein production |
| 11/24/2005 | WO2005068650A3 Various human chromosomal regions implicated in premature canities |
| 11/24/2005 | WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations |
| 11/24/2005 | WO2004060303A3 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 11/24/2005 | WO2003052121A3 Method of reducing angiogenesis |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261489 Immune system disorders, cancer, viral diseases |
| 11/24/2005 | US20050261482 Regulation of human serine-threonine protein kinase |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261249 administering antisense oligonucleotides comprising nuclease resistant backbones and targeting sequences which forms heteroduplex with target region of processed human RNA transcripts affecting expression of proteins and inhibits expression of active proteins in target cancer cells |
| 11/24/2005 | US20050261234 GFAP-based gene therapy for treatment of retinal diseases |
| 11/24/2005 | US20050261233 Modulation of glucose-6-phosphatase translocase expression |
| 11/24/2005 | US20050261232 Non-natural ribonuclease conjugates as cytotoxic agents |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261228 Polynucleotide; diagnosis, therapy of Crohn's disese, encephalomyelitis, antitumor agents; modulate interleukins |
| 11/24/2005 | US20050261226 Methods and compositions for the treatment of cancer with oligonucleotides directed against Egr-1 |
| 11/24/2005 | US20050261225 Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 11/24/2005 | US20050261223 Contacting the cell with a small inhibitory RNA (siRNA) that inhibits expression of a RIP140 polypeptide, thereby increasing glucose transport in the cell; eating disoders; metabolism; antidiabetic agents; brown fat |
| 11/24/2005 | US20050261221 Compositions and methods for enhanced delivery of compounds via transfection complexes |
| 11/24/2005 | US20050261220 Tumor treating combinations, compositions and methods |
| 11/24/2005 | US20050261219 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA) |
| 11/24/2005 | US20050261218 Oligomeric compounds and compositions for use in modulation small non-coding RNAs |
| 11/24/2005 | US20050261217 Modulation of pumilio 1 expression |
| 11/24/2005 | US20050261216 Modulation of Nanos 1 expression |
| 11/24/2005 | US20050261215 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 11/24/2005 | US20050261214 Complexes for transferring substances of interest into a cell |